Trust versus concerns-how parents reason when they accept HPV vaccination for their young daughter

Maria Gottvall, Maria Grandahl, Anna T Höglund, Margareta Larsson, Christina Stenhammar, Bengt Andrae, Tanja Tydén, Maria Gottvall, Maria Grandahl, Anna T Höglund, Margareta Larsson, Christina Stenhammar, Bengt Andrae, Tanja Tydén

Abstract

Background: From spring of 2012, human papillomavirus (HPV) vaccine against cervical cancer is offered free of charge to all girls aged 10-12 years through a school-based vaccination programme in Sweden. The aim of this study was to explore how parents reason when they accept HPV vaccination for their young daughter and also their views on HPV-related information.

Methods: Individual interviews with parents (n = 27) of 11-12-year-old girls. The interviews were recorded, transcribed verbatim, and analysed using thematic content analysis.

Results: Three themes emerged through the analysis: Trust versus concern, Responsibility to protect against severe disease, and Information about HPV and HPV vaccination is important. The parents expressed trust in recommendations from authorities and thought it was convenient with school-based vaccination. They believed that cervical cancer was a severe disease and felt a responsibility to protect their daughter from it. Some had certain concerns regarding side effects and vaccine safety, and wished for a dialogue with the school nurse to bridge the information gaps.

Conclusions: Trust in the recommendations from authorities and a wish to protect their daughter from a severe disease outweighed concerns about side effects. A school-based vaccination programme is convenient for parents, and the school nurse has an important role in bridging information gaps. The findings from this qualitative study cannot be generalized; however, it can provide a better understanding of how parents might reason when they accept the HPV vaccination for their daughter.

Figures

Figure 1.
Figure 1.
Themes and categories that emerged through the analysis.

References

    1. Mosina L, Martin R, Eckert L. . . 2010 Available from. accessed 9 January 2012.
    1. The National Board of Health and Welfare [Socialstyrelsen] . . Available from. accessed 14 August 2012.
    1. Limia A, Pachon I. . . Euro Surveill. 2011;16(pii):19873. Available from.
    1. Swedish Association of Local Authorities and Regions [Sveriges Kommuner och Landsting, SKL] . . 2013 Available from. accessed 28 March 2013.
    1. Leval A, Herweijer E, Arnheim-Dahlstrom L, Walum H, Frans E, Sparen P, et al. . J Infect Dis. 2012;206:860–6.
    1. Leval A, Herweijer E, Ploner A, Eloranta S, Fridman Simard J, Dillner J, et al. . J Natl Cancer Inst. 2013;105:469–74.
    1. Widgren K, Simonsen J, Valentiner-Branth P, Molbak K. . Vaccine. 2011;29:9663–7.
    1. Reiter PL, Brewer NT, Gottlieb SL, McRee AL, Smith JS. . Soc Sci Med. 2009;69:475–80.
    1. Ogilvie G, Anderson M, Marra F, McNeil S, Pielak K, Dawar M, et al. . PLoS Med. 2010;7:e1000270.
    1. Trim K, Nagji N, Elit L, Roy K. . Obstet Gynecol Int. 2012;2012:921236.
    1. Dempsey AF, Abraham LM, Dalton V, Ruffin M. . Ann Epidemiol. 2009;19:531–8.
    1. Perkins RB, Pierre-Joseph N, Marquez C, Iloka S, Clark JA. . J Pediatr. 2010;157:617–22.
    1. Dahlstrom LA, Tran TN, Lundholm C, Young C, Sundstrom K, Sparen P. . Int J Cancer. 2010;126:500–7.
    1. Marlow LA. . Br J Cancer. 2011;105:486–92.
    1. Brewer NT, Gottlieb SL, Reiter PL, McRee AL, Liddon N, Markowitz L, et al. . Sex Transm Dis. 2011;38:197–204.
    1. Marshall H, Ryan P, Roberton D, Baghurst P. . Aust N Z J Public Health. 2007;31:235–42.
    1. Burnard P, Gill P, Stewart K, Treasure E, Chadwick B. . Br Dent J. 2008;204:429–32.
    1. Guba E, Lincoln Y. Fourth generation evaluation. Newbury Park, CA: Sage publications; 1989.
    1. Ward KF, Menzies RI, Quinn HE, Campbell-Lloyd S. . N S W Public Health Bull. 2010;21:237–42.
    1. Medical Products Agency [Läkemedelsverket] . 2012 Available from. cited 18 June 2012.
    1. Swedish Institute for Communicable Disease Control [Smittskyddsinstitutet] . 2013 Available from. cited 8 February 2013.
    1. Abdelmutti N, Hoffman-Goetz L. . Women Health. 2009;49:422–40.
    1. Cooper Robbins SC, Bernard D, McCaffery K, Brotherton J, Garland S, Skinner SR. . Vaccine. 2010;28:3398–408.

Source: PubMed

Sponsors en medewerkers

Medische omstandigheden

Geneesmiddelinterventies

3
Abonneren